Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Dexamethasone Market - Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026: The Rise of Dexamethasone as a Lifesaving Treatment for Critically Ill COVID-19 Patients - ResearchAndMarkets.com

January 7, 2021 GMT

DUBLIN--(BUSINESS WIRE)--Jan 7, 2021--

The “Dexamethasone Market By Formulation type, By Application, and End user - Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026” report has been added to ResearchAndMarkets.com’s offering.


The report covers forecast and analysis for the Dexamethasone market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).

The study includes drivers and restraints for the Dexamethasone market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Dexamethasone market on a global as well as regional level.

In order to give the users of this report a comprehensive view on the Dexamethasone market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Formulation type, Patient type, Application, End user, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the Dexamethasone market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the Dexamethasone market on global and regional basis.

Market Dynamics

Market Drivers

  • The rise of dexamethasone as a lifesaving treatment for critically ill COVID-19 patients due to a sudden outburst
  • Increasing various inflammatory conditions
  • Growing prevalence of diseases


  • Side effects associated with use of Dexamethasone



  • High investment in research and development in Dexamethasone market

Porter’s Five Forces Analysis

The report segments global Dexamethasone market as follows:

Global Dexamethasone Market: Formulation type

  • Liquid
  • Tablet
  • Solution for injection
  • Other

Global Dexamethasone Market: By Patient type

  • Adult
  • Pediatric
  • Geriatric

Global Dexamethasone Market: By Application

  • Anti-inflammatory and immunosuppressant effects
  • Respiratory Distress Syndrome
  • COVID-19
  • Others

Global Dexamethasone Market: By End user

  • Hospitals
  • Clinics
  • Pharmacy & Drug Stores
  • Online Pharmacies

Global Dexamethasone Market: By Region

  • North America
  • The U.S.
  • Canada
  • Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Company Profiles

  • Cadila Healthcare Ltd.
  • Wockhardt Ltd
  • Fresenius Kabi
  • Dwarkesh Pharmaceuticals Private Limited
  • Schwitz Biotech
  • Lexine Technochem Private Limited
  • Mapro Lifescience
  • Therawin Formulations
  • Shervotec Pharmaceuticals
  • Therawin Formulations
  • Acichem Laboratories
  • Quality Nexgen Pharmaceuticals Pvt Ltd
  • Kern Pharma SL
  • Symbiotic Pharma
  • AuroMedics

For more information about this report visit https://www.researchandmarkets.com/r/h2b1ks

View source version on businesswire.com:https://www.businesswire.com/news/home/20210107005726/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 01/07/2021 11:42 AM/DISC: 01/07/2021 11:42 AM